Recent reports highlighting the scarcity of key medicines and non-essentialdrugs within the Pakistani market have raised significant concernsregarding the well-being of the population. This shortage not only resultsin inflated medication prices due to limited supply but also poses asubstantial risk to public health.
One alarming aspect of this shortage revolves around the unavailability oflife-saving medications, including insulin, vaccines, and immunoglobulins.These drugs are crucial for managing chronic conditions and preventingsevere illnesses. The absence of timely access to these medications leavesindividuals vulnerable to their diseases, potentially burdening healthcareservices and endangering lives.
Furthermore, the scarcity of medicines has created a thriving black market,with medicines being illicitly imported from neighboring countries such asAfghanistan, Iran, and India. This illicit trade undermines existingregulatory systems, giving rise to concerns about the authenticity,quality, and efficacy of these drugs. There’s no guarantee that thesemedications are not expired, properly dosed, or even authentic, posing agrave threat to public health through the use of substandard or counterfeitdrugs.
The disruption in the supply chain of medicines has been exacerbated byimport restrictions on active pharmaceutical ingredients (API) and thediscontinuation of their production. Manufacturers reducing or ceasing theimport of raw materials has led to shortages in both essential andnon-essential drugs. Additionally, the drastic devaluation of the rupee andthe imposition of a four percent sales tax on imported medicines havefurther aggravated the ongoing crisis.
To address these pressing issues, the government must collaborate closelywith pharmaceutical manufacturers, health authorities, and regulatorybodies. Strict regulations and monitoring mechanisms should be put in placeto curb the black market. Enhanced border control and crackdowns on illegalsmuggling operations are vital steps to ensure the safety and authenticityof medicines available in the market. It is imperative to identify the rootcauses and take appropriate measures to ensure the continuous availabilityof essential medicines.







